Gsa Capital Partners LLP Royalty Pharma PLC Transaction History

Gsa Capital Partners LLP

$1.32 Billion
Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Gsa Capital Partners LLP holds 44,535 shares of RPRX stock, worth $1.36 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

44,535

Previous 48,007 7.23%

Holding current value

$1.36 Million

Previous $1.27 Million 0.47%

% of portfolio

0.1%

Previous 0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$25.63 - $29.27 $88,987 - $101,625	-3,472 Reduced 7.23%	44,535 $1.26 Million
Q2 2024 Aug 15, 2024	BUY	$26.26 - $29.9 $1.05 Million - $1.19 Million	39,966 Added 497.03%	48,007 $1.27 Million
Q1 2024 May 03, 2024	SELL	$27.46 - $31.33 $170,142 - $194,120	-6,196 Reduced 43.52%	8,041 $244,000
Q4 2023 Feb 16, 2024	SELL	$26.21 - $29.22 $1.48 Million - $1.65 Million	-56,554 Reduced 79.89%	14,237 $399,000
Q3 2023 Nov 15, 2023	BUY	$26.26 - $31.38 $1.52 Million - $1.82 Million	58,012 Added 453.96%	70,791 $1.92 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $8,584 - $10,602	-290 Reduced 2.22%	12,779 $392,000
Q1 2023 May 12, 2023	BUY	$32.77 - $39.4 $428,271 - $514,918	13,069 New	13,069 $470,000
Q2 2022 Aug 09, 2022	BUY	$37.53 - $44.22 $483,161 - $569,288	12,874 New	12,874 $541,000
Q1 2022 May 11, 2022	SELL	$37.46 - $42.44 $294,323 - $333,451	-7,857 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $276,330 - $333,765	7,857 New	7,857 $313,000
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $268,881 - $314,265	-7,440 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$39.85 - $46.63 $296,484 - $346,927	7,440 New	7,440 $305,000
Q1 2021 May 10, 2021	SELL	$42.34 - $52.82 $198,998 - $248,254	-4,700 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$36.12 - $50.05 $169,764 - $235,235	4,700 New	4,700 $235,000

Others Institutions Holding RPRX

# of Institutions

410

Shares Held

284M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $13.4B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Royalty Pharma PLC Transaction History